Acarix A/S (ACARIX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.442x

Based on the latest financial reports, Acarix A/S (ACARIX) has a cash flow conversion efficiency ratio of -0.442x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-16.89 Million ≈ $-1.82 Million USD) by net assets (Skr38.17 Million ≈ $4.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Acarix A/S balance sheet independence to measure how much of total assets are equity-financed.

Acarix A/S - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Acarix A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Acarix A/S total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Acarix A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acarix A/S ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Marti Gayrimenkul Yatirim Ortakligi AS IS:MRGYO	0.009x
MFS Investment Grade Municipal Trust NYSE:CXH	0.023x
Jeil Steel Mfg Co. Ltd KQ:023440	-0.047x
Camino Minerals Corporation V:COR	-0.025x
Foamit Oyj HE:FOAMIT	0.050x
3S KOREA Co. Ltd KQ:060310	-0.004x
Tycoons Worldwide Group (Thailand) Public Company Limited BK:TYCN	-0.050x
Tongyang Pile Inc KQ:228340	0.000x

Annual Cash Flow Conversion Efficiency for Acarix A/S (2014–2025)

The table below shows the annual cash flow conversion efficiency of Acarix A/S from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see ACARIX stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr38.17 Million ≈ $4.11 Million	Skr-48.38 Million ≈ $-5.21 Million	-1.268x	-51.52%
2024-12-31	Skr75.70 Million ≈ $8.15 Million	Skr-63.33 Million ≈ $-6.81 Million	-0.837x	+46.65%
2023-12-31	Skr51.88 Million ≈ $5.58 Million	Skr-81.37 Million ≈ $-8.76 Million	-1.568x	-8.55%
2022-12-31	Skr51.83 Million ≈ $5.58 Million	Skr-74.87 Million ≈ $-8.06 Million	-1.445x	-202.56%
2021-12-31	Skr100.54 Million ≈ $10.82 Million	Skr-48.01 Million ≈ $-5.17 Million	-0.477x	-6.90%
2020-12-31	Skr82.14 Million ≈ $8.84 Million	Skr-36.69 Million ≈ $-3.95 Million	-0.447x	+23.17%
2019-12-31	Skr76.60 Million ≈ $8.24 Million	Skr-44.53 Million ≈ $-4.79 Million	-0.581x	-32.32%
2018-12-31	Skr87.88 Million ≈ $9.46 Million	Skr-38.61 Million ≈ $-4.15 Million	-0.439x	-39.74%
2017-12-31	Skr128.94 Million ≈ $13.88 Million	Skr-40.54 Million ≈ $-4.36 Million	-0.314x	-439.92%
2016-12-31	Skr155.52 Million ≈ $16.74 Million	Skr-9.06 Million ≈ $-974.57K	-0.058x	+91.81%
2015-12-31	Skr12.14 Million ≈ $1.31 Million	Skr-8.63 Million ≈ $-928.83K	-0.711x	+48.48%
2014-12-31	Skr15.12 Million ≈ $1.63 Million	Skr-20.87 Million ≈ $-2.25 Million	-1.380x	--

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$31.27 Million

Skr290.59 Million SEK

Market Cap Rank

#23567 Global

#459 in Sweden

Share Price

Skr0.25

Change (1 day)

-0.99%

52-Week Range

Skr0.24 - Skr0.41

All Time High

Skr20.62